Parallax Volatility Advisers’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73M | Sell |
25,071
-46,740
| -65% | -$3.23M | ﹤0.01% | 219 |
|
|
2025
Q1 | $4.99M | Sell |
71,811
-61,276
| -46% | -$4.26M | 0.01% | 130 |
|
|
2024
Q4 | $11.4M | Buy |
133,087
+31,477
| +31% | +$2.71M | 0.02% | 94 |
|
|
2024
Q3 | $12.1M | Buy |
101,610
+63,434
| +166% | +$7.55M | 0.02% | 71 |
|
|
2024
Q2 | $5.45M | Buy |
38,176
+30,390
| +390% | +$4.34M | 0.01% | 147 |
|
|
2024
Q1 | $1,000K | Buy |
+7,786
| New | +$1,000K | ﹤0.01% | 294 |
|
|
2023
Q3 | – | Sell |
-919
| Closed | -$149K | – | 996 |
|
|
2023
Q2 | $149K | Buy |
+919
| New | +$149K | ﹤0.01% | 502 |
|
|
2022
Q4 | – | Sell |
-6,107
| Closed | -$608K | – | 1253 |
|
|
2022
Q3 | $608K | Buy |
6,107
+3,847
| +170% | +$383K | ﹤0.01% | 454 |
|
|
2022
Q2 | $252K | Buy |
+2,260
| New | +$252K | ﹤0.01% | 612 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1294 |
|
|
2020
Q3 | – | Sell |
-306
| Closed | -$20K | – | 1239 |
|
|
2020
Q2 | $20K | Buy |
+306
| New | +$20K | ﹤0.01% | 928 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | – | – | 1632 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1892 |
|
|
2019
Q1 | – | Sell |
-20,432
| Closed | -$941K | – | 2051 |
|
|
2018
Q4 | $941K | Sell |
20,432
-8,592
| -30% | -$396K | ﹤0.01% | 375 |
|
|
2018
Q3 | $1.37M | Buy |
+29,024
| New | +$1.37M | ﹤0.01% | 250 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$5K | – | 1874 |
|
|
2018
Q1 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 1031 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3339 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1608 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1612 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 1451 |
|